Ocular Co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation

Effective pharmacotherapy during glaucoma treatment depends on interventions that reduce intraocular pressure (IOP) and retain the IOP lowering effect for sufficient time so as to reduce dosing frequency and enhance patient adherence. Combination anti-glaucoma therapy and dosage forms that increase...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Elissavet Taka, Christina Karavasili, Nikolaos Bouropoulos, Thomas Moschakis, Dimitrios D. Andreadis, Constantinos K. Zacharis, Dimitrios G. Fatouros
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Subjects:	self-assembling peptide hydrogel glaucoma timolol maleate/brimonidine tartrate combination ex vivo ocular permeability
Online Access:	https://www.mdpi.com/1424-8247/13/6/126